Synopsis of recent research by authors named "Shannon Rowe"
- Shannon Rowe’s research primarily focuses on molecular profiling of cancers, including gynecologic and CNS tumors, emphasizing the correlation between molecular signatures and clinical significance for precision medicine.
- In her study on gynecologic cancers, Rowe analyzed 95 cases using The JAX ActionSeq™ NGS panel and compared findings to TCGA datasets, highlighting the need for better correlation between molecular profiles and clinical outcomes.
- Rowe also explored mutation yields using a custom 212-gene NGS panel across various solid tumors, discovering a clinically significant variant detection rate of 13% among 261 tested cases, underscoring the variability in mutation prevalence across different cancer types.